AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Verifica-M OD 500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (100mg)

Overview Verifica-M OD 500 Tablet SR

Verifica-M OD 500 SR tablets combine two active ingredients to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Verifica-M OD 500 SR may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal therapeutic outcomes are achieved through consistent medication adherence, complemented by a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose readings, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. This medication plays a crucial role in long-term glucose control and complication prevention. Continued adherence to your prescribed diet and exercise plan is essential for overall diabetes management. Lifestyle modifications are integral to successful diabetes control. Potential side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a possibility, particularly when used with insulin or sulfonylureas; understanding hypoglycemia recognition and management is vital. This medication is not universally suitable. Prior to commencing treatment, disclose any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical advice before use. Inform your physician of all medications you are currently taking to ensure medication compatibility and safety. Alcohol consumption should be minimized due to its potential to reduce blood sugar. Your physician will monitor renal function and blood glucose levels throughout your treatment.

Uses of Verifica-M OD 500 Tablet SR

Managing type 2 diabetes

Major Benefits of Verifica-M OD 500 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Verifica-M OD 500 Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with a meal.

Common Side effects of Verifica-M OD 500 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Verifica-M OD 500 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Verifica-M OD 500 SR tablets should be administered with a meal.

How Verifica-M OD 500 Tablet SR works:

Each Verifica-M OD 500 SR tablet contains a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Verifica-M OD 500 Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Verifica-M OD 500mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Verifica-M OD 500mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Verifica-M OD 500 SR tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should not take Verifica-M OD 500 Tablet SR; its use is considered potentially hazardous in this population. Medical advice is recommended.

What if you forget to take Verifica-M OD 500 Tablet SR :

Should you forget a dose of Verifica-M OD 500mg sustained-release tablet, take it immediately upon remembering. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Verifica-M OD 500 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Verifica-M OD 500 Tablet SR

Verifica-M OD 500 Tablet SR rarely causes hypoglycemia by itself. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Verifica-M OD 500 Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Consult your doctor before taking any other medication.
Verifica-M OD 500 Tablet SR is contraindicated in patients with allergies to its components or excipients. Its use is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Verifica-M OD 500 Tablet SR combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Verifica-M OD 500 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this risk is heightened in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Verifica-M OD 500 Tablet SR and seek immediate medical attention.
Prolonged use of Verifica-M OD 500 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological issues.
Using Verifica-M OD 500 Tablet SR as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, upset stomach, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Verifica-M OD 500 Tablet ...
108
MRP 132
18% off